(Q31148183)

29 June 2017

title

Classical MALDI-MS versus CE-based ESI-MS proteomic profiling in urine for clinical applications (English)

1 reference

matrix-assisted laser desorption/ionization

29 June 2017

main subject

0 references

Angelique Stalmach

3

0 references

Amaya Albalat

Amaya Albalat

1

0 references

Joost P Schanstra

Joost P Schanstra

4

0 references

Harald Mischak

Harald Mischak

5

0 references

Holger Husi

2

Holger Husi

1 reference

29 June 2017

publication date

1 January 2014

1 reference

29 June 2017

1 reference

29 June 2017

volume

6

1 reference

29 June 2017

issue

2

1 reference

29 June 2017

page(s)

247-266

1 reference

Next-generation proteomics: towards an integrative view of proteome dynamics.

29 June 2017

cites work

1 reference

https://api.crossref.org/works/10.4155%2FBIO.13.313

Protein profiling for cancer biomarker discovery using matrix-assisted laser desorption/ionization time-of-flight mass spectrometry and infrared imaging: a review

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FBIO.13.313

Biomarkers and surrogate endpoints: preferred definitions and conceptual framework

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FBIO.13.313

Clinical proteomics: A need to define the field and to begin to set adequate standards

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FBIO.13.313

Urinary biomarkers for prostate cancer: a review

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FBIO.13.313

A recipe for proteomics diagnostic test development: the OVA1 test, from biomarker discovery to FDA clearance

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FBIO.13.313

Profiling the proteome in renal transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FBIO.13.313

Near infrared spectroscopy compared to liquid chromatography coupled to mass spectrometry and capillary electrophoresis as a detection tool for peptide reaction monitoring

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FBIO.13.313

Depletion of abundant plasma proteins and limitations of plasma proteomics.

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FBIO.13.313

Profiling plasma peptides for the identification of potential ageing biomarkers in Chinese Han adults

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FBIO.13.313

Differential protein profiling of synovial fluid from rheumatoid arthritis and osteoarthritis patients using LC-MALDI TOF/TOF.

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FBIO.13.313

Plasma biomarker discovery using 3D protein profiling coupled with label-free quantitation

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FBIO.13.313

Time course proteomic profiling of human myocardial infarction plasma samples: an approach to new biomarker discovery

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FBIO.13.313

Markers of vascular disease in plasma from patients with chronic kidney disease identified by proteomic analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FBIO.13.313

Pre-analytical factors influencing the stability of cerebrospinal fluid proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FBIO.13.313

Standardized peptidome profiling of human cerebrospinal fluid by magnetic bead separation and matrix-assisted laser desorption/ionization time-of-flight mass spectrometry

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FBIO.13.313

High-resolution proteome/peptidome analysis of body fluids by capillary electrophoresis coupled with MS.

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FBIO.13.313

CSF biomarker discovery using label-free nano-LC-MS based proteomic profiling: technical aspects.

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FBIO.13.313

Identification of biomarkers for diagnosis and progression of MS by MALDI-TOF mass spectrometry.

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FBIO.13.313

Novel panel of cerebrospinal fluid biomarkers for the prediction of progression to Alzheimer dementia in patients with mild cognitive impairment

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FBIO.13.313

Cerebrospinal fluid biomarkers for major depression confirm relevance of associated pathophysiology

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FBIO.13.313

Proteomic profiling of cerebrospinal fluid in Creutzfeldt-Jakob disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FBIO.13.313

Proteomic profiling of cerebrospinal fluid in parkinsonian disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FBIO.13.313

One decade of salivary proteomics: current approaches and outstanding challenges.

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FBIO.13.313

The proteomes of human parotid and submandibular/sublingual gland salivas collected as the ductal secretions

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FBIO.13.313

Large-scale identification of proteins in human salivary proteome by liquid chromatography/mass spectrometry and two-dimensional gel electrophoresis-mass spectrometry

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FBIO.13.313

Saliva: diagnostics and therapeutic perspectives

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FBIO.13.313

A quantitative proteomic analysis uncovers the relevance of CUL3 in bladder cancer aggressiveness

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FBIO.13.313

Individualised proteome profiling of human endometrial tumours improves detection of new prognostic markers

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FBIO.13.313

Proteomics in uremia and renal disease

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FBIO.13.313

Comprehensive human urine standards for comparability and standardization in clinical proteome analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FBIO.13.313

Analysis of the urine proteome via a combination of multi-dimensional approaches

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FBIO.13.313

Discovery of potential bladder cancer biomarkers by comparative urine proteomics and analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FBIO.13.313

Urine proteins identified by two-dimensional differential gel electrophoresis facilitate the differential diagnoses of scrapie

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FBIO.13.313

Shotgun proteomics identifies proteins specific for acute renal transplant rejection.

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FBIO.13.313

Proteomic analysis of urinary upper gastrointestinal cancer markers

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FBIO.13.313

CE-MS in biomarker discovery, validation, and clinical application

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FBIO.13.313

Preanalytical and analytical variation of surface-enhanced laser desorption-ionization time-of-flight mass spectrometry of human serum

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FBIO.13.313

Mass spectrometry for the detection of differentially expressed proteins: a comparison of surface-enhanced laser desorption/ionization and capillary electrophoresis/mass spectrometry

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FBIO.13.313

Reproducibility of mass spectrometry based protein profiles for diagnosis of ovarian cancer across clinical studies: A systematic review.

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FBIO.13.313

Integrating high-throughput technologies in the quest for effective biomarkers for ovarian cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FBIO.13.313

Robust analysis of the yeast proteome under 50 kDa by molecular-mass-based fractionation and top-down mass spectrometry

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FBIO.13.313

Identification of chemical-adducted proteins in urine by multi-dimensional protein identification technology (LC/LC-MS/MS).

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FBIO.13.313

Performance of different separation methods interfaced in the same MS-reflection TOF detector: a comparison of performance between CE versus HPLC for biomarker analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FBIO.13.313

High-efficiency liquid chromatography-mass spectrometry separations with 50 mm, 250 mm, and 1 m long polymer-based monolithic capillary columns for the characterization of complex proteolytic digests.

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FBIO.13.313

Absolute quantification of selected proteins in the human osteoarthritic secretome.

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FBIO.13.313

Multi-profile Bayesian alignment model for LC-MS data analysis with integration of internal standards.

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FBIO.13.313

Matrix-assisted laser desorption ionization mass-spectrometry of proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FBIO.13.313

Cinnamic acid derivatives as matrices for ultraviolet laser desorption mass spectrometry of proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FBIO.13.313

Comparative mapping of recombinant proteins and glycoproteins by plasma desorption and matrix-assisted laser desorption/ionization mass spectrometry

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FBIO.13.313

4-Chloro-alpha-cyanocinnamic acid is an advanced, rationally designed MALDI matrix

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FBIO.13.313

Dried-droplet probe preparation on AnchorChip targets for navigating the acquisition of matrix-assisted laser desorption/ionization time-of-flight spectra by fluorescence of matrix/analyte crystals

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FBIO.13.313

Laser desorption ionization of proteins with molecular masses exceeding 10,000 daltons

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FBIO.13.313

Improved mass accuracy in matrix-assisted laser desorption/ionization time-of-flight mass spectrometry of peptides

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FBIO.13.313

The first decade of MALDI protein profiling: a lesson in translational biomarker research.

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FBIO.13.313

Graphite supported preparation (GSP) of α-cyano-4-hydroxycinnamic acid (CHCA) for matrix-assisted laser desorption/ionization mass spectrometry (MALDI-MS) for peptides and proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FBIO.13.313

Comparison between the matrices alpha-cyano-4-hydroxycinnamic acid and 4-chloro-alpha-cyanocinnamic acid for trypsin, chymotrypsin, and pepsin digestions by MALDI-TOF mass spectrometry

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FBIO.13.313

Recent developments in methods and technology for analysis of biological samples by MALDI-TOF-MS.

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FBIO.13.313

Modern MALDI time-of-flight mass spectrometry

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FBIO.13.313

Sample preparation and bioinformatics in MALDI profiling of urinary proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FBIO.13.313

Proteomics: from basic research to diagnostic application. A review of requirements & needs

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FBIO.13.313

Investigating the quantitative nature of MALDI-TOF MS.

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FBIO.13.313

Influence of matrix solution conditions on the MALDI-MS analysis of peptides and proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FBIO.13.313

The dominance of arginine-containing peptides in MALDI-derived tryptic mass fingerprints of proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FBIO.13.313

Advances in urinary proteome analysis and biomarker discovery

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FBIO.13.313

Capillary electrophoresis-mass spectrometry for the analysis of intact proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FBIO.13.313

Combining capillary electrophoresis with mass spectrometry for applications in proteomics

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FBIO.13.313

Capillary electrophoresis-mass spectrometry as a powerful tool in clinical diagnosis and biomarker discovery

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FBIO.13.313

Peptidomic analysis of rat urine using capillary electrophoresis coupled to mass spectrometry.

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FBIO.13.313

Capillary electrophoresis-mass spectrometry as a powerful tool in biomarker discovery and clinical diagnosis: an update of recent developments

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FBIO.13.313

Selective effect of ethanol on norepinephrine- and nicotine-induced emesis in cats

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FBIO.13.313

Twenty years of interface development for capillary electrophoresis-electrospray ionization-mass spectrometry

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FBIO.13.313

Biomarker discovery by CE-MS enables sequence analysis via MS/MS with platform-independent separation

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FBIO.13.313

Recent advances in capillary electrophoresis for biomarker discovery.

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FBIO.13.313

CE at the omics level: towards systems biology--an update

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FBIO.13.313

Electrolyte systems for on-line CE-MS: detection requirements and separation possibilities

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FBIO.13.313

Capillary electrophoresis/mass spectrometry relevant to pharmaceutical and biotechnological applications

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FBIO.13.313

Determination of peptides and proteins in human urine with capillary electrophoresis-mass spectrometry, a suitable tool for the establishment of new diagnostic markers

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FBIO.13.313

Technical aspects and inter-laboratory variability in native peptide profiling: the CE-MS experience

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FBIO.13.313

Recent advances in capillary electrophoresis coupled to mass spectrometry for clinical proteomic applications

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FBIO.13.313

Detection of pre-neoplastic and neoplastic prostate disease by MALDI profiling of urine

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FBIO.13.313

Standardized preprocessing of urine for proteome analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FBIO.13.313

Non-invasive detection of drug toxicity in rats by solid-phase extraction and MALDI-TOF analysis of urine samples.

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FBIO.13.313

Optimization of analytical and pre-analytical conditions for MALDI-TOF-MS human urine protein profiles

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FBIO.13.313

Enhancement of sensitivity and resolution of surface-enhanced laser desorption/ionization time-of-flight mass spectrometric records for serum peptides using time-series analysis techniques

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FBIO.13.313

Optimal preparation methods for automated matrix-assisted laser desorption/ionization time-of-flight mass spectrometry profiling of low molecular weight proteins and peptides

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FBIO.13.313

Reproducibility in protein profiling by MALDI-TOF mass spectrometry

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FBIO.13.313

Quantitative matrix-assisted laser desorption/ionization mass spectrometry

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FBIO.13.313

Mass spectrometry to classify non-small-cell lung cancer patients for clinical outcome after treatment with epidermal growth factor receptor tyrosine kinase inhibitors: a multicohort cross-institutional study.

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FBIO.13.313

Quantitative urinary proteome analysis for biomarker evaluation in chronic kidney disease

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FBIO.13.313

A comparison between MALDI-MS and CE-MS data for biomarker assessment in chronic kidney diseases.

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FBIO.13.313

Bottom-up proteome analysis of E. coli using capillary zone electrophoresis-tandem mass spectrometry with an electrokinetic sheath-flow electrospray interface

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FBIO.13.313

MALDI in-source decay, from sequencing to imaging

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FBIO.13.313

Analysing signalling networks by mass spectrometry

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FBIO.13.313

Metabolome 2.0: quantitative genetics and network biology of metabolic phenotypes

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FBIO.13.313

Revolutionizing medicine in the 21st century through systems approaches

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FBIO.13.313

Systems biology, proteomics, and the future of health care: toward predictive, preventative, and personalized medicine

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FBIO.13.313

Data merging for integrated microarray and proteomic analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FBIO.13.313

Harnessing systems biology approaches to engineer functional microvascular networks

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FBIO.13.313

Bioinformatics for cancer management in the post-genome era.

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FBIO.13.313

Data standards for 'omic' science

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FBIO.13.313

Discovery and validation of new protein biomarkers for urothelial cancer: a prospective analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FBIO.13.313

Assessment of high-throughput high-resolution MALDI-TOF-MS of urinary peptides for the detection of muscle-invasive bladder cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FBIO.13.313

Pilot study of capillary electrophoresis coupled to mass spectrometry as a tool to define potential prostate cancer biomarkers in urine

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FBIO.13.313

Urine in clinical proteomics

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FBIO.13.313

Discovery and validation of urinary biomarkers for prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FBIO.13.313

Molecular profiling of cholangiocarcinoma shows potential for targeted therapy treatment decisions

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FBIO.13.313

Proteomics-based identification of α-enolase as a potential prognostic marker in cholangiocarcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FBIO.13.313

Urine proteomic analysis differentiates cholangiocarcinoma from primary sclerosing cholangitis and other benign biliary disorders.

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FBIO.13.313

All-cause mortality attributable to chronic kidney disease: a prospective cohort study based on 462 293 adults in Taiwan

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FBIO.13.313

Naturally occurring human urinary peptides for use in diagnosis of chronic kidney disease

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FBIO.13.313

Low molecular weight proteins in urines from healthy subjects as well as diabetic, nephropathic and diabetic-nephropathic patients: a MALDI study

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FBIO.13.313

Study of diabetic nephropathy in the proteomic era.

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FBIO.13.313

Identification of urinary protein pattern in type 1 diabetic adolescents with early diabetic nephropathy by a novel combined proteome analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FBIO.13.313

Urinary proteomics in diabetes and CKD

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FBIO.13.313

Multicentric validation of proteomic biomarkers in urine specific for diabetic nephropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FBIO.13.313

Increased hepcidin expression in colorectal carcinogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FBIO.13.313

Urinary proteomics for early diagnosis in diabetic nephropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FBIO.13.313

A urinary peptide biomarker set predicts worsening of albuminuria in type 2 diabetes mellitus.

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FBIO.13.313

Filter-based method for background removal in high-sensitivity wide-field-surface-enhanced Raman scattering imagingin vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FBIO.13.313

Capillary electrophoresis coupled to mass spectrometer for automated and robust polypeptide determination in body fluids for clinical use

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FBIO.13.313

Capillary Electrophoresis Coupled to Mass Spectrometry for Proteomic Profiling of Human Urine and Biomarker Discovery

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FBIO.13.313

Prediction of Muscle-invasive Bladder Cancer Using Urinary Proteomics

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FBIO.13.313

Proteomic analysis for the assessment of diabetic renal damage in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FBIO.13.313

Urinary excretion of twenty peptides forms an early and accurate diagnostic pattern of acute kidney injury

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FBIO.13.313

Urinary Proteome Analysis to Exclude Severe Vesicoureteral Reflux

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FBIO.13.313

21 January 2018

Identifiers

DOI

10.4155/BIO.13.313

1 reference

29 June 2017

1 reference